# ACCELERON PHARMA INC

ACCELERON PHARMA INC is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** ACCELERON PHARMA INC
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001280600

## About

ACCELERON PHARMA INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001280600, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2021-02-25, it reported annual revenue of USD 92,523,000; net income of USD -166,030,000; total assets of USD 932,337,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $92.5M (USD 92,523,000)
- **Net income:** -$166.0M (USD -166,030,000)
- **Total assets:** $932.3M (USD 932,337,000)
- **Cash and equivalents:** $671.0M (USD 670,952,000)
- **Operating cash flow:** -$130.3M (USD -130,327,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $74.0M (USD 73,993,000)
- **Net income:** -$124.9M (USD -124,858,000)
- **Total assets:** $504.9M (USD 504,906,000)
- **Cash and equivalents:** $237.7M (USD 237,677,000)
- **Operating cash flow:** -$93.8M (USD -93,804,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $14.0M (USD 13,991,000)
- **Net income:** -$118.9M (USD -118,871,000)
- **Total assets:** $314.8M (USD 314,821,000)
- **Cash and equivalents:** $144.1M (USD 144,052,000)
- **Operating cash flow:** -$94.7M (USD -94,706,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $13.5M (USD 13,481,000)
- **Net income:** -$108.5M (USD -108,454,000)
- **Total assets:** $389.2M (USD 389,177,000)
- **Cash and equivalents:** $100.2M (USD 100,150,000)
- **Operating cash flow:** -$76.7M (USD -76,730,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2021-11-22 — period 2021-11-19 — FORM 8-K
- Form 10-Q — filed 2021-11-04 — period 2021-09-30 — 10-Q
- Form 8-K — filed 2021-11-04 — period 2021-11-04 — 8-K
- Form 8-K — filed 2021-10-27 — period 2021-10-27 — 8-K
- Form SC 13D — filed 2021-10-05 — ACCELERON PHARMA INC.
- Form 8-K — filed 2021-09-30 — period 2021-09-29 — FORM 8-K
- Form 10-Q — filed 2021-08-05 — period 2021-06-30 — 10-Q
- Form 8-K — filed 2021-08-05 — period 2021-08-05 — 8-K
- Form 8-K — filed 2021-07-28 — period 2021-07-28 — 8-K
- Form 8-K — filed 2021-06-22 — period 2021-06-22 — 8-K
- Form 8-K — filed 2021-06-21 — period 2021-06-16 — 8-K
- Form 8-K — filed 2021-06-17 — period 2021-06-11 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/acceleron-pharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology